Matthews International Capital Management LLC Purchases Shares of 22,749 Lam Research Corporation $LRCX

Matthews International Capital Management LLC acquired a new stake in Lam Research Corporation (NASDAQ:LRCX) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 22,749 shares of the semiconductor company’s stock, valued at approximately $3,046,000. Lam Research accounts for 0.7% of Matthews International Capital Management LLC’s holdings, making the stock its 27th biggest holding.

A number of other large investors have also recently made changes to their positions in LRCX. IMG Wealth Management Inc. purchased a new position in Lam Research in the second quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the 2nd quarter valued at $27,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research during the 2nd quarter worth $29,000. Delos Wealth Advisors LLC purchased a new stake in shares of Lam Research during the 2nd quarter worth $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research during the second quarter worth $31,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Price Performance

LRCX stock opened at $178.07 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $223.66 billion, a P/E ratio of 39.22, a PEG ratio of 2.06 and a beta of 1.77. The business has a 50 day simple moving average of $158.39 and a 200-day simple moving average of $126.21. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $179.80.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s quarterly revenue was up 27.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s dividend payout ratio is 22.91%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Hsbc Global Res upgraded Lam Research to a “hold” rating in a research note on Tuesday, September 30th. The Goldman Sachs Group raised their target price on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. UBS Group restated a “buy” rating and set a $200.00 target price (up previously from $175.00) on shares of Lam Research in a research note on Tuesday. JPMorgan Chase & Co. increased their price target on shares of Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 23rd. Finally, Cowen restated a “buy” rating on shares of Lam Research in a research report on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average price target of $161.21.

Insider Buying and Selling

In related news, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the transaction, the director owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. Corporate insiders own 0.31% of the company’s stock.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.